Lachén-Montes and colleagues in 2019 study applied quantitative proteomics to analyze pathological effects on the olfactory bulb in subjects with supranuclear palsy (PSP) and frontotemporal lobar degeneration (FTLD-TDP43). Here, TARDBP is linked to supranuclear palsy, progressive, 1.